W. F. Symmans
All authors
About
Publications While At HealthPartners
selected publications
Journal Article
Adjuvant platinum versus capecitabine for residual, invasive, triple-negative breast cancer: patient-reported outcomes in ECOG-ACRIN EA1131
.
Cancer.
2024
Randomized phase III postoperative trial of platinum-based chemotherapy versus capecitabine in patients with residual triple-negative breast cancer following neoadjuvant chemotherapy: ECOG-ACRIN EA1131
.
Journal of Clinical Oncology.
2021
Contact
full name
W. F.
Symmans
Quick Info
Collaboration
Co-author network
Map of science